Literature DB >> 15519893

CART in feeding and obesity.

Richard G Hunter1, Kelly Philpot, Aleksandra Vicentic, Geraldina Dominguez, George W Hubert, Michael J Kuhar.   

Abstract

CART (cocaine- and amphetamine-regulated transcript) peptides are neurotransmitters that have received much attention as mediators of feeding behavior and body-weight regulation in mammals. CART peptides and their mRNAs are found in many brain regions and in peripheral tissues that are involved in feeding, and many animal studies implicate CART as an inhibitor of feeding. Animal studies also demonstrate that CART expression is regulated by both leptin and glucocorticoids, two hormones known to be associated with the regulation of body weight. A recent study also links a mutation in the CART gene to obesity in humans. These peptides might become targets for drug development in the area of obesity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519893     DOI: 10.1016/j.tem.2004.09.010

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  20 in total

Review 1.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Maternal nutrition and the programming of obesity: The brain.

Authors:  Beverly Sara Mühlhäusler; Clare L Adam; I Caroline McMillen
Journal:  Organogenesis       Date:  2008-07       Impact factor: 2.500

3.  RNAi-mediated silencing of prohormone convertase (PC) 5/6 expression leads to impairment in processing of cocaine- and amphetamine-regulated transcript (CART) precursor.

Authors:  Jeffrey Stein; Rohan Shah; Donald F Steiner; Arunangsu Dey
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

4.  Gender differences in Nociceptin/Orphanin FQ-induced food intake in strains derived from rats prone (WOKW) and resistant (Dark Agouti) to metabolic syndrome: a possible involvement of the cocaine- and amphetamine-regulated transcript system.

Authors:  Serena Battistoni; Ingrid Kloting; Carlo Cifani; Maurizio Massi; Carlo Polidori
Journal:  Genes Nutr       Date:  2010-11-13       Impact factor: 5.523

Review 5.  Expanding neurotransmitters in the hypothalamic neurocircuitry for energy balance regulation.

Authors:  Yuanzhong Xu; Qingchun Tong
Journal:  Protein Cell       Date:  2011-11-06       Impact factor: 14.870

Review 6.  Cocaine- and amphetamine-regulated transcript peptides play a role in drug abuse and are potential therapeutic targets.

Authors:  Michael J Kuhar; Jason N Jaworski; George W Hubert; Kelly B Philpot; Geraldina Dominguez
Journal:  AAPS J       Date:  2005-09-02       Impact factor: 4.009

7.  Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner.

Authors:  Shin-Ichi Nishio; Yann Gibert; Liubov Berekelya; Laure Bernard; Frédéric Brunet; Etienne Guillot; Jean-Christophe Le Bail; Juan Antonio Sánchez; Anne Marie Galzin; Gerard Triqueneaux; Vincent Laudet
Journal:  Mol Endocrinol       Date:  2012-06-14

8.  Leptin-Induced CART (Cocaine- and Amphetamine-Regulated Transcript) Is a Novel Intraovarian Mediator of Obesity-Related Infertility in Females.

Authors:  Xiaoting Ma; Emily Hayes; Hen Prizant; Rajesh K Srivastava; Stephen R Hammes; Aritro Sen
Journal:  Endocrinology       Date:  2016-01-05       Impact factor: 4.736

9.  Cocaine- and amphetamine-regulated transcript peptide immunoreactivity in the brain of the CCK-1 receptor deficient obese OLETF rat.

Authors:  Hajnalka Abraham; Mihai Covasa; Andras Hajnal
Journal:  Exp Brain Res       Date:  2009-06-17       Impact factor: 1.972

Review 10.  CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system.

Authors:  George W Hubert; Douglas C Jones; Mark C Moffett; George Rogge; Michael J Kuhar
Journal:  Biochem Pharmacol       Date:  2007-07-26       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.